niacinamide has been researched along with Latent Tuberculosis in 1 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Latent Tuberculosis: The dormant form of TUBERCULOSIS where the person shows no obvious symptoms and no sign of the causative agent (Mycobacterium tuberculosis) in the SPUTUM despite being positive for tuberculosis infection skin test.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The authors postulate that sorafenib could increase the risk of progression from latent to active tuberculosis, and urge vigilance and possible screening for latent tuberculosis in patients who are treated with sorafenib." | 3.78 | Sorafenib-induced tuberculosis reactivation. ( O'Connor, TM; O'Reilly, SP; Power, DG; Teo, M, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Teo, M | 1 |
| O'Connor, TM | 1 |
| O'Reilly, SP | 1 |
| Power, DG | 1 |
1 other study available for niacinamide and Latent Tuberculosis
| Article | Year |
|---|---|
Sorafenib-induced tuberculosis reactivation.
Topics: Aged; Antineoplastic Agents; Antitubercular Agents; Carcinoma, Renal Cell; Humans; Kidney Neoplasms; | 2012 |